Brenig Therapeutics

Company

Last deal

$65M

Amount

Series A

Stage

24.07.2022

Date

1

all rounds

$65M

Total amount

General

About Company

Brenig Therapeutics develops therapies for neurodegenerative disorders.

Last funding type

Series A

IPO status

Private

Description

Brenig Therapeutics develops therapies for neurodegenerative disorders.

Contacts